SAFETY OF INTERFERON BETA 1A FOR A SUBCUTANEOUS ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH DISSEMINATED SCLEROSIS
The onset of disseminated sclerosis occurs in childhood and juvenile age in 10% of patients. nevertheless, all immunomodulatory drugs for a treatment of this disease intended for adult population of patients, and there's an age limitation to the administration of these medications. There's...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-06-01
|
Series: | Вопросы современной педиатрии |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/1409 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!